Hillsdale Investment Management Inc. decreased its holdings in Plexus Corp. (NASDAQ:PLXS – Free Report) by 4.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 47,625 shares of the technology company’s stock after selling 2,300 shares during the period. Hillsdale Investment Management Inc. owned 0.18% of Plexus worth $7,001,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in the company. Allworth Financial LP lifted its position in shares of Plexus by 20.8% in the fourth quarter. Allworth Financial LP now owns 302 shares of the technology company’s stock worth $44,000 after buying an additional 52 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its position in shares of Plexus by 1.2% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,175 shares of the technology company’s stock worth $908,000 after buying an additional 71 shares in the last quarter. Uncommon Cents Investing LLC lifted its position in shares of Plexus by 0.8% in the fourth quarter. Uncommon Cents Investing LLC now owns 9,925 shares of the technology company’s stock worth $1,459,000 after buying an additional 75 shares in the last quarter. Choreo LLC lifted its position in shares of Plexus by 1.9% in the fourth quarter. Choreo LLC now owns 5,131 shares of the technology company’s stock worth $767,000 after buying an additional 94 shares in the last quarter. Finally, Arizona State Retirement System lifted its position in shares of Plexus by 1.3% in the third quarter. Arizona State Retirement System now owns 7,993 shares of the technology company’s stock worth $1,157,000 after buying an additional 102 shares in the last quarter. 94.45% of the stock is currently owned by hedge funds and other institutional investors.
Plexus Trading Up 0.2%
Shares of PLXS stock opened at $268.36 on Friday. Plexus Corp. has a 1 year low of $115.35 and a 1 year high of $275.83. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.54 and a quick ratio of 0.74. The stock’s 50 day simple moving average is $237.81 and its two-hundred day simple moving average is $194.54. The company has a market cap of $7.18 billion, a PE ratio of 39.23 and a beta of 0.88.
Insider Buying and Selling at Plexus
In other news, insider Victor (Pang Hau) Tan sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $271.23, for a total transaction of $813,690.00. Following the transaction, the insider owned 10,457 shares of the company’s stock, valued at approximately $2,836,252.11. This represents a 22.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Todd P. Kelsey sold 1,000 shares of the stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $274.75, for a total value of $274,750.00. Following the completion of the sale, the chief executive officer owned 71,388 shares in the company, valued at approximately $19,613,853. The trade was a 1.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 20,471 shares of company stock worth $5,275,401 over the last ninety days. Company insiders own 1.78% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts recently commented on PLXS shares. Benchmark reiterated a “buy” rating and issued a $220.00 target price on shares of Plexus in a research report on Monday, March 16th. Wall Street Zen upgraded Plexus from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Weiss Ratings upgraded Plexus from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, May 11th. Needham & Company LLC boosted their target price on Plexus from $206.00 to $285.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Finally, Zacks Research downgraded Plexus from a “hold” rating to a “strong sell” rating in a research report on Wednesday, May 20th. Five equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $234.17.
View Our Latest Research Report on Plexus
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
See Also
- Five stocks we like better than Plexus
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
